nodes	percent_of_prediction	percent_of_DWPC	metapath
Terlipressin—AVPR2—collecting duct of renal tubule—kidney cancer	0.221	0.483	CbGeAlD
Terlipressin—AVPR2—nephron—kidney cancer	0.0986	0.215	CbGeAlD
Terlipressin—AVPR2—urine—kidney cancer	0.0791	0.172	CbGeAlD
Terlipressin—AVPR2—nephron tubule—kidney cancer	0.0213	0.0464	CbGeAlD
Terlipressin—AVPR2—renal system—kidney cancer	0.0193	0.0422	CbGeAlD
Terlipressin—AVPR2—kidney—kidney cancer	0.0187	0.0408	CbGeAlD
Terlipressin—Torsade de pointes—Sunitinib—kidney cancer	0.00555	0.0113	CcSEcCtD
Terlipressin—Respiratory distress—Vincristine—kidney cancer	0.00518	0.0106	CcSEcCtD
Terlipressin—Abdominal cramps—Vincristine—kidney cancer	0.00488	0.00993	CcSEcCtD
Terlipressin—Hot flush—Pazopanib—kidney cancer	0.00458	0.00932	CcSEcCtD
Terlipressin—Menopausal symptoms—Pazopanib—kidney cancer	0.00454	0.00924	CcSEcCtD
Terlipressin—Skin exfoliation—Everolimus—kidney cancer	0.00445	0.00906	CcSEcCtD
Terlipressin—Cardiac failure—Pazopanib—kidney cancer	0.00439	0.00894	CcSEcCtD
Terlipressin—Hyponatraemia—Pazopanib—kidney cancer	0.0043	0.00876	CcSEcCtD
Terlipressin—Skin exfoliation—Erlotinib—kidney cancer	0.00429	0.00874	CcSEcCtD
Terlipressin—Pulmonary oedema—Everolimus—kidney cancer	0.00415	0.00844	CcSEcCtD
Terlipressin—Respiratory distress—Paclitaxel—kidney cancer	0.00412	0.00838	CcSEcCtD
Terlipressin—Respiratory failure—Sunitinib—kidney cancer	0.00396	0.00807	CcSEcCtD
Terlipressin—Skin necrosis—Doxorubicin—kidney cancer	0.00396	0.00806	CcSEcCtD
Terlipressin—Skin exfoliation—Sorafenib—kidney cancer	0.00386	0.00786	CcSEcCtD
Terlipressin—Skin exfoliation—Sunitinib—kidney cancer	0.00372	0.00757	CcSEcCtD
Terlipressin—Hot flush—Everolimus—kidney cancer	0.00362	0.00736	CcSEcCtD
Terlipressin—Menopausal symptoms—Everolimus—kidney cancer	0.00358	0.0073	CcSEcCtD
Terlipressin—Atrial fibrillation—Everolimus—kidney cancer	0.00357	0.00727	CcSEcCtD
Terlipressin—Cardiac failure—Everolimus—kidney cancer	0.00347	0.00706	CcSEcCtD
Terlipressin—Pulmonary oedema—Sunitinib—kidney cancer	0.00346	0.00705	CcSEcCtD
Terlipressin—Hyponatraemia—Everolimus—kidney cancer	0.0034	0.00691	CcSEcCtD
Terlipressin—Respiratory distress—Capecitabine—kidney cancer	0.00338	0.00688	CcSEcCtD
Terlipressin—Respiratory failure—Vincristine—kidney cancer	0.00335	0.00683	CcSEcCtD
Terlipressin—Acute coronary syndrome—Pazopanib—kidney cancer	0.00325	0.00663	CcSEcCtD
Terlipressin—Myocardial infarction—Pazopanib—kidney cancer	0.00324	0.00659	CcSEcCtD
Terlipressin—Respiratory failure—Gemcitabine—kidney cancer	0.00318	0.00647	CcSEcCtD
Terlipressin—Torsade de pointes—Capecitabine—kidney cancer	0.00306	0.00623	CcSEcCtD
Terlipressin—Hot flush—Sunitinib—kidney cancer	0.00302	0.00615	CcSEcCtD
Terlipressin—Bradycardia—Pazopanib—kidney cancer	0.00302	0.00614	CcSEcCtD
Terlipressin—Cardiac failure—Sorafenib—kidney cancer	0.00301	0.00613	CcSEcCtD
Terlipressin—Menopausal symptoms—Sunitinib—kidney cancer	0.00299	0.0061	CcSEcCtD
Terlipressin—Skin exfoliation—Gemcitabine—kidney cancer	0.00298	0.00607	CcSEcCtD
Terlipressin—Hyponatraemia—Sorafenib—kidney cancer	0.00295	0.006	CcSEcCtD
Terlipressin—Cardiac disorder—Temsirolimus—kidney cancer	0.00292	0.00594	CcSEcCtD
Terlipressin—Cardiac failure—Sunitinib—kidney cancer	0.00289	0.00589	CcSEcCtD
Terlipressin—Ventricular extrasystoles—Paclitaxel—kidney cancer	0.00289	0.00589	CcSEcCtD
Terlipressin—Angiopathy—Temsirolimus—kidney cancer	0.00285	0.00581	CcSEcCtD
Terlipressin—Hyponatraemia—Sunitinib—kidney cancer	0.00284	0.00578	CcSEcCtD
Terlipressin—Ventricular fibrillation—Capecitabine—kidney cancer	0.0028	0.0057	CcSEcCtD
Terlipressin—Pulmonary oedema—Gemcitabine—kidney cancer	0.00278	0.00566	CcSEcCtD
Terlipressin—Cardiac disorder—Pazopanib—kidney cancer	0.00275	0.0056	CcSEcCtD
Terlipressin—Malnutrition—Temsirolimus—kidney cancer	0.00274	0.00558	CcSEcCtD
Terlipressin—Angiopathy—Pazopanib—kidney cancer	0.00269	0.00547	CcSEcCtD
Terlipressin—Respiratory failure—Paclitaxel—kidney cancer	0.00266	0.00542	CcSEcCtD
Terlipressin—Malnutrition—Pazopanib—kidney cancer	0.00258	0.00525	CcSEcCtD
Terlipressin—Acute coronary syndrome—Vinblastine—kidney cancer	0.00258	0.00525	CcSEcCtD
Terlipressin—Acute coronary syndrome—Everolimus—kidney cancer	0.00257	0.00523	CcSEcCtD
Terlipressin—Myocardial infarction—Vinblastine—kidney cancer	0.00256	0.00522	CcSEcCtD
Terlipressin—Myocardial infarction—Everolimus—kidney cancer	0.00255	0.0052	CcSEcCtD
Terlipressin—Skin exfoliation—Paclitaxel—kidney cancer	0.0025	0.00508	CcSEcCtD
Terlipressin—Acute coronary syndrome—Erlotinib—kidney cancer	0.00248	0.00505	CcSEcCtD
Terlipressin—Myocardial infarction—Erlotinib—kidney cancer	0.00247	0.00502	CcSEcCtD
Terlipressin—Hyponatraemia—Vincristine—kidney cancer	0.0024	0.00488	CcSEcCtD
Terlipressin—Ventricular extrasystoles—Capecitabine—kidney cancer	0.00238	0.00484	CcSEcCtD
Terlipressin—Hypertension—Temsirolimus—kidney cancer	0.00236	0.00481	CcSEcCtD
Terlipressin—Chest pain—Temsirolimus—kidney cancer	0.00233	0.00475	CcSEcCtD
Terlipressin—Cardiac failure—Gemcitabine—kidney cancer	0.00232	0.00473	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Temsirolimus—kidney cancer	0.00232	0.00471	CcSEcCtD
Terlipressin—Acute coronary syndrome—Sorafenib—kidney cancer	0.00223	0.00454	CcSEcCtD
Terlipressin—Hypertension—Pazopanib—kidney cancer	0.00223	0.00453	CcSEcCtD
Terlipressin—Myocardial infarction—Sorafenib—kidney cancer	0.00222	0.00452	CcSEcCtD
Terlipressin—Chest pain—Pazopanib—kidney cancer	0.0022	0.00447	CcSEcCtD
Terlipressin—Nervous system disorder—Temsirolimus—kidney cancer	0.00219	0.00446	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Pazopanib—kidney cancer	0.00218	0.00444	CcSEcCtD
Terlipressin—Cardiac disorder—Everolimus—kidney cancer	0.00217	0.00442	CcSEcCtD
Terlipressin—Skin disorder—Temsirolimus—kidney cancer	0.00217	0.00442	CcSEcCtD
Terlipressin—AVPR2—Arf6 trafficking events—CTNNA1—kidney cancer	0.00215	0.0443	CbGpPWpGaD
Terlipressin—Acute coronary syndrome—Sunitinib—kidney cancer	0.00215	0.00437	CcSEcCtD
Terlipressin—Angiopathy—Everolimus—kidney cancer	0.00212	0.00432	CcSEcCtD
Terlipressin—Nervous system disorder—Pazopanib—kidney cancer	0.00206	0.0042	CcSEcCtD
Terlipressin—Skin exfoliation—Capecitabine—kidney cancer	0.00205	0.00417	CcSEcCtD
Terlipressin—Skin disorder—Pazopanib—kidney cancer	0.00204	0.00416	CcSEcCtD
Terlipressin—Malnutrition—Everolimus—kidney cancer	0.00204	0.00415	CcSEcCtD
Terlipressin—Hot flush—Paclitaxel—kidney cancer	0.00203	0.00413	CcSEcCtD
Terlipressin—Menopausal symptoms—Paclitaxel—kidney cancer	0.00201	0.0041	CcSEcCtD
Terlipressin—Atrial fibrillation—Paclitaxel—kidney cancer	0.002	0.00408	CcSEcCtD
Terlipressin—Dyspnoea—Temsirolimus—kidney cancer	0.00199	0.00406	CcSEcCtD
Terlipressin—Bradycardia—Sunitinib—kidney cancer	0.00199	0.00405	CcSEcCtD
Terlipressin—Malnutrition—Erlotinib—kidney cancer	0.00197	0.004	CcSEcCtD
Terlipressin—Cardiac failure—Paclitaxel—kidney cancer	0.00194	0.00396	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Temsirolimus—kidney cancer	0.00193	0.00393	CcSEcCtD
Terlipressin—Hyponatraemia—Paclitaxel—kidney cancer	0.00191	0.00388	CcSEcCtD
Terlipressin—Cardiac disorder—Sorafenib—kidney cancer	0.00188	0.00384	CcSEcCtD
Terlipressin—Dyspnoea—Pazopanib—kidney cancer	0.00188	0.00382	CcSEcCtD
Terlipressin—Angiopathy—Sorafenib—kidney cancer	0.00184	0.00375	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Pazopanib—kidney cancer	0.00182	0.0037	CcSEcCtD
Terlipressin—Acute coronary syndrome—Vincristine—kidney cancer	0.00182	0.0037	CcSEcCtD
Terlipressin—Cardiac disorder—Sunitinib—kidney cancer	0.00181	0.00369	CcSEcCtD
Terlipressin—Myocardial infarction—Vincristine—kidney cancer	0.0018	0.00368	CcSEcCtD
Terlipressin—Angiopathy—Sunitinib—kidney cancer	0.00177	0.00361	CcSEcCtD
Terlipressin—Malnutrition—Sorafenib—kidney cancer	0.00177	0.0036	CcSEcCtD
Terlipressin—Abdominal pain—Temsirolimus—kidney cancer	0.00177	0.0036	CcSEcCtD
Terlipressin—Hypertension—Vinblastine—kidney cancer	0.00177	0.00359	CcSEcCtD
Terlipressin—Hypertension—Everolimus—kidney cancer	0.00176	0.00358	CcSEcCtD
Terlipressin—Chest pain—Everolimus—kidney cancer	0.00173	0.00353	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Everolimus—kidney cancer	0.00172	0.00351	CcSEcCtD
Terlipressin—Acute coronary syndrome—Gemcitabine—kidney cancer	0.00172	0.00351	CcSEcCtD
Terlipressin—Myocardial infarction—Gemcitabine—kidney cancer	0.00171	0.00349	CcSEcCtD
Terlipressin—Malnutrition—Sunitinib—kidney cancer	0.0017	0.00346	CcSEcCtD
Terlipressin—Chest pain—Erlotinib—kidney cancer	0.00167	0.00341	CcSEcCtD
Terlipressin—Hot flush—Capecitabine—kidney cancer	0.00166	0.00339	CcSEcCtD
Terlipressin—Abdominal pain—Pazopanib—kidney cancer	0.00166	0.00339	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—kidney cancer	0.00166	0.00338	CcSEcCtD
Terlipressin—Menopausal symptoms—Capecitabine—kidney cancer	0.00165	0.00336	CcSEcCtD
Terlipressin—Atrial fibrillation—Capecitabine—kidney cancer	0.00164	0.00335	CcSEcCtD
Terlipressin—Nervous system disorder—Everolimus—kidney cancer	0.00163	0.00332	CcSEcCtD
Terlipressin—Tachycardia—Everolimus—kidney cancer	0.00162	0.0033	CcSEcCtD
Terlipressin—Skin disorder—Everolimus—kidney cancer	0.00161	0.00329	CcSEcCtD
Terlipressin—Cardiac failure—Capecitabine—kidney cancer	0.0016	0.00325	CcSEcCtD
Terlipressin—Nervous system disorder—Erlotinib—kidney cancer	0.00157	0.0032	CcSEcCtD
Terlipressin—Hyponatraemia—Capecitabine—kidney cancer	0.00156	0.00318	CcSEcCtD
Terlipressin—Skin disorder—Erlotinib—kidney cancer	0.00156	0.00317	CcSEcCtD
Terlipressin—Cardiac disorder—Vincristine—kidney cancer	0.00153	0.00312	CcSEcCtD
Terlipressin—Ventricular extrasystoles—Doxorubicin—kidney cancer	0.00153	0.00312	CcSEcCtD
Terlipressin—Diarrhoea—Temsirolimus—kidney cancer	0.00153	0.00311	CcSEcCtD
Terlipressin—Hypertension—Sorafenib—kidney cancer	0.00153	0.00311	CcSEcCtD
Terlipressin—Angiopathy—Vincristine—kidney cancer	0.0015	0.00305	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.00149	0.00304	CcSEcCtD
Terlipressin—Dyspnoea—Everolimus—kidney cancer	0.00148	0.00302	CcSEcCtD
Terlipressin—Hypertension—Sunitinib—kidney cancer	0.00147	0.00299	CcSEcCtD
Terlipressin—Cardiac disorder—Gemcitabine—kidney cancer	0.00146	0.00296	CcSEcCtD
Terlipressin—Chest pain—Sunitinib—kidney cancer	0.00145	0.00295	CcSEcCtD
Terlipressin—Acute coronary syndrome—Paclitaxel—kidney cancer	0.00144	0.00294	CcSEcCtD
Terlipressin—Diarrhoea—Pazopanib—kidney cancer	0.00144	0.00293	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.00144	0.00293	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Everolimus—kidney cancer	0.00144	0.00292	CcSEcCtD
Terlipressin—Myocardial infarction—Paclitaxel—kidney cancer	0.00143	0.00292	CcSEcCtD
Terlipressin—Dyspnoea—Erlotinib—kidney cancer	0.00143	0.00291	CcSEcCtD
Terlipressin—Angiopathy—Gemcitabine—kidney cancer	0.00142	0.0029	CcSEcCtD
Terlipressin—Vomiting—Temsirolimus—kidney cancer	0.00142	0.00289	CcSEcCtD
Terlipressin—Nervous system disorder—Sorafenib—kidney cancer	0.00142	0.00288	CcSEcCtD
Terlipressin—Skin disorder—Sorafenib—kidney cancer	0.0014	0.00285	CcSEcCtD
Terlipressin—Headache—Temsirolimus—kidney cancer	0.0014	0.00285	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Erlotinib—kidney cancer	0.00138	0.00282	CcSEcCtD
Terlipressin—Nervous system disorder—Sunitinib—kidney cancer	0.00136	0.00277	CcSEcCtD
Terlipressin—Skin disorder—Sunitinib—kidney cancer	0.00135	0.00275	CcSEcCtD
Terlipressin—Vomiting—Pazopanib—kidney cancer	0.00134	0.00273	CcSEcCtD
Terlipressin—Bradycardia—Paclitaxel—kidney cancer	0.00134	0.00272	CcSEcCtD
Terlipressin—Nausea—Temsirolimus—kidney cancer	0.00133	0.0027	CcSEcCtD
Terlipressin—Skin exfoliation—Doxorubicin—kidney cancer	0.00132	0.00269	CcSEcCtD
Terlipressin—Abdominal pain—Vinblastine—kidney cancer	0.00132	0.00269	CcSEcCtD
Terlipressin—Headache—Pazopanib—kidney cancer	0.00132	0.00269	CcSEcCtD
Terlipressin—Abdominal pain—Everolimus—kidney cancer	0.00131	0.00268	CcSEcCtD
Terlipressin—Dyspnoea—Sorafenib—kidney cancer	0.00129	0.00262	CcSEcCtD
Terlipressin—Abdominal pain—Erlotinib—kidney cancer	0.00127	0.00258	CcSEcCtD
Terlipressin—Nausea—Pazopanib—kidney cancer	0.00125	0.00255	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Sorafenib—kidney cancer	0.00125	0.00254	CcSEcCtD
Terlipressin—Hypertension—Vincristine—kidney cancer	0.00124	0.00253	CcSEcCtD
Terlipressin—Dyspnoea—Sunitinib—kidney cancer	0.00124	0.00252	CcSEcCtD
Terlipressin—Pulmonary oedema—Doxorubicin—kidney cancer	0.00123	0.00251	CcSEcCtD
Terlipressin—Cardiac disorder—Paclitaxel—kidney cancer	0.00122	0.00248	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Sunitinib—kidney cancer	0.0012	0.00244	CcSEcCtD
Terlipressin—Angiopathy—Paclitaxel—kidney cancer	0.00119	0.00243	CcSEcCtD
Terlipressin—Acute coronary syndrome—Capecitabine—kidney cancer	0.00118	0.00241	CcSEcCtD
Terlipressin—Hypertension—Gemcitabine—kidney cancer	0.00118	0.0024	CcSEcCtD
Terlipressin—Myocardial infarction—Capecitabine—kidney cancer	0.00118	0.0024	CcSEcCtD
Terlipressin—Chest pain—Gemcitabine—kidney cancer	0.00116	0.00237	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.00115	0.00235	CcSEcCtD
Terlipressin—Nervous system disorder—Vincristine—kidney cancer	0.00115	0.00235	CcSEcCtD
Terlipressin—Desmopressin—PTGS1—kidney cancer	0.00114	0.636	CrCbGaD
Terlipressin—Malnutrition—Paclitaxel—kidney cancer	0.00114	0.00233	CcSEcCtD
Terlipressin—Diarrhoea—Vinblastine—kidney cancer	0.00114	0.00232	CcSEcCtD
Terlipressin—AVPR1B—G alpha (q) signalling events—ITPR2—kidney cancer	0.00114	0.0235	CbGpPWpGaD
Terlipressin—Abdominal pain—Sorafenib—kidney cancer	0.00114	0.00232	CcSEcCtD
Terlipressin—Diarrhoea—Everolimus—kidney cancer	0.00114	0.00232	CcSEcCtD
Terlipressin—Abdominal pain—Sunitinib—kidney cancer	0.0011	0.00223	CcSEcCtD
Terlipressin—Diarrhoea—Erlotinib—kidney cancer	0.0011	0.00223	CcSEcCtD
Terlipressin—Bradycardia—Capecitabine—kidney cancer	0.0011	0.00223	CcSEcCtD
Terlipressin—Nervous system disorder—Gemcitabine—kidney cancer	0.00109	0.00222	CcSEcCtD
Terlipressin—Skin disorder—Gemcitabine—kidney cancer	0.00108	0.0022	CcSEcCtD
Terlipressin—Hot flush—Doxorubicin—kidney cancer	0.00107	0.00219	CcSEcCtD
Terlipressin—Menopausal symptoms—Doxorubicin—kidney cancer	0.00106	0.00217	CcSEcCtD
Terlipressin—Vomiting—Vinblastine—kidney cancer	0.00106	0.00216	CcSEcCtD
Terlipressin—Vomiting—Everolimus—kidney cancer	0.00106	0.00215	CcSEcCtD
Terlipressin—Headache—Vinblastine—kidney cancer	0.00105	0.00213	CcSEcCtD
Terlipressin—Headache—Everolimus—kidney cancer	0.00104	0.00212	CcSEcCtD
Terlipressin—Abdominal pain—Dactinomycin—kidney cancer	0.00104	0.00212	CcSEcCtD
Terlipressin—Cardiac failure—Doxorubicin—kidney cancer	0.00103	0.00209	CcSEcCtD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR2—kidney cancer	0.00102	0.0211	CbGpPWpGaD
Terlipressin—Vomiting—Erlotinib—kidney cancer	0.00102	0.00208	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Vincristine—kidney cancer	0.00101	0.00206	CcSEcCtD
Terlipressin—Hyponatraemia—Doxorubicin—kidney cancer	0.00101	0.00205	CcSEcCtD
Terlipressin—Headache—Erlotinib—kidney cancer	0.001	0.00205	CcSEcCtD
Terlipressin—Cardiac disorder—Capecitabine—kidney cancer	0.001	0.00204	CcSEcCtD
Terlipressin—Dyspnoea—Gemcitabine—kidney cancer	0.000993	0.00202	CcSEcCtD
Terlipressin—Nausea—Vinblastine—kidney cancer	0.000991	0.00202	CcSEcCtD
Terlipressin—Nausea—Everolimus—kidney cancer	0.000987	0.00201	CcSEcCtD
Terlipressin—Diarrhoea—Sorafenib—kidney cancer	0.000987	0.00201	CcSEcCtD
Terlipressin—Hypertension—Paclitaxel—kidney cancer	0.000987	0.00201	CcSEcCtD
Terlipressin—Angiopathy—Capecitabine—kidney cancer	0.000978	0.00199	CcSEcCtD
Terlipressin—Chest pain—Paclitaxel—kidney cancer	0.000973	0.00198	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000966	0.00197	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000962	0.00196	CcSEcCtD
Terlipressin—AVPR1B—G alpha (q) signalling events—ANXA1—kidney cancer	0.000956	0.0197	CbGpPWpGaD
Terlipressin—Nausea—Erlotinib—kidney cancer	0.000953	0.00194	CcSEcCtD
Terlipressin—Diarrhoea—Sunitinib—kidney cancer	0.00095	0.00193	CcSEcCtD
Terlipressin—AVPR1B—Peptide ligand-binding receptors—ANXA1—kidney cancer	0.000944	0.0195	CbGpPWpGaD
Terlipressin—AVPR2—Arf6 trafficking events—CDH1—kidney cancer	0.000941	0.0194	CbGpPWpGaD
Terlipressin—Malnutrition—Capecitabine—kidney cancer	0.000938	0.00191	CcSEcCtD
Terlipressin—Abdominal pain—Vincristine—kidney cancer	0.000928	0.00189	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—OR4C13—kidney cancer	0.000921	0.019	CbGpPWpGaD
Terlipressin—Vomiting—Sorafenib—kidney cancer	0.000917	0.00187	CcSEcCtD
Terlipressin—Nervous system disorder—Paclitaxel—kidney cancer	0.000915	0.00186	CcSEcCtD
Terlipressin—Tachycardia—Paclitaxel—kidney cancer	0.00091	0.00185	CcSEcCtD
Terlipressin—Skin disorder—Paclitaxel—kidney cancer	0.000906	0.00184	CcSEcCtD
Terlipressin—Headache—Sorafenib—kidney cancer	0.000904	0.00184	CcSEcCtD
Terlipressin—Diarrhoea—Dactinomycin—kidney cancer	0.000899	0.00183	CcSEcCtD
Terlipressin—Vomiting—Sunitinib—kidney cancer	0.000883	0.0018	CcSEcCtD
Terlipressin—Headache—Sunitinib—kidney cancer	0.00087	0.00177	CcSEcCtD
Terlipressin—Nausea—Sorafenib—kidney cancer	0.000857	0.00175	CcSEcCtD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—kidney cancer	0.000855	0.0176	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—OR4C13—kidney cancer	0.000836	0.0173	CbGpPWpGaD
Terlipressin—Vomiting—Dactinomycin—kidney cancer	0.000836	0.0017	CcSEcCtD
Terlipressin—Dyspnoea—Paclitaxel—kidney cancer	0.000832	0.00169	CcSEcCtD
Terlipressin—Nausea—Sunitinib—kidney cancer	0.000825	0.00168	CcSEcCtD
Terlipressin—Hypertension—Capecitabine—kidney cancer	0.00081	0.00165	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000805	0.00164	CcSEcCtD
Terlipressin—Diarrhoea—Vincristine—kidney cancer	0.000804	0.00164	CcSEcCtD
Terlipressin—Chest pain—Capecitabine—kidney cancer	0.000798	0.00163	CcSEcCtD
Terlipressin—AVPR2—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000794	0.0164	CbGpPWpGaD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000793	0.00161	CcSEcCtD
Terlipressin—AVPR1A—G alpha (q) signalling events—ITPR2—kidney cancer	0.000791	0.0163	CbGpPWpGaD
Terlipressin—Nausea—Dactinomycin—kidney cancer	0.000781	0.00159	CcSEcCtD
Terlipressin—Diarrhoea—Gemcitabine—kidney cancer	0.000762	0.00155	CcSEcCtD
Terlipressin—Nervous system disorder—Capecitabine—kidney cancer	0.000751	0.00153	CcSEcCtD
Terlipressin—Tachycardia—Capecitabine—kidney cancer	0.000747	0.00152	CcSEcCtD
Terlipressin—Vomiting—Vincristine—kidney cancer	0.000747	0.00152	CcSEcCtD
Terlipressin—Skin disorder—Capecitabine—kidney cancer	0.000744	0.00151	CcSEcCtD
Terlipressin—Abdominal pain—Paclitaxel—kidney cancer	0.000737	0.0015	CcSEcCtD
Terlipressin—Headache—Vincristine—kidney cancer	0.000736	0.0015	CcSEcCtD
Terlipressin—Vomiting—Gemcitabine—kidney cancer	0.000708	0.00144	CcSEcCtD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR2—kidney cancer	0.000707	0.0146	CbGpPWpGaD
Terlipressin—Bradycardia—Doxorubicin—kidney cancer	0.000707	0.00144	CcSEcCtD
Terlipressin—Headache—Gemcitabine—kidney cancer	0.000698	0.00142	CcSEcCtD
Terlipressin—Nausea—Vincristine—kidney cancer	0.000698	0.00142	CcSEcCtD
Terlipressin—AVPR2—Arf6 trafficking events—CTNNB1—kidney cancer	0.000694	0.0143	CbGpPWpGaD
Terlipressin—Dyspnoea—Capecitabine—kidney cancer	0.000682	0.00139	CcSEcCtD
Terlipressin—AVPR1A—G alpha (q) signalling events—ANXA1—kidney cancer	0.000663	0.0137	CbGpPWpGaD
Terlipressin—Nausea—Gemcitabine—kidney cancer	0.000662	0.00135	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000661	0.00135	CcSEcCtD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—ANXA1—kidney cancer	0.000654	0.0135	CbGpPWpGaD
Terlipressin—Desmopressin—PTGS2—kidney cancer	0.000654	0.364	CrCbGaD
Terlipressin—AVPR2—Peptide ligand-binding receptors—ANXA1—kidney cancer	0.00065	0.0134	CbGpPWpGaD
Terlipressin—Cardiac disorder—Doxorubicin—kidney cancer	0.000645	0.00131	CcSEcCtD
Terlipressin—AVPR1A—GPCR downstream signaling—OR4C13—kidney cancer	0.000638	0.0132	CbGpPWpGaD
Terlipressin—Diarrhoea—Paclitaxel—kidney cancer	0.000638	0.0013	CcSEcCtD
Terlipressin—AVPR2—GPCR downstream signaling—OR4C13—kidney cancer	0.000634	0.0131	CbGpPWpGaD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—ANXA1—kidney cancer	0.000633	0.0131	CbGpPWpGaD
Terlipressin—Angiopathy—Doxorubicin—kidney cancer	0.00063	0.00128	CcSEcCtD
Terlipressin—Abdominal pain—Capecitabine—kidney cancer	0.000605	0.00123	CcSEcCtD
Terlipressin—Malnutrition—Doxorubicin—kidney cancer	0.000605	0.00123	CcSEcCtD
Terlipressin—Vomiting—Paclitaxel—kidney cancer	0.000593	0.00121	CcSEcCtD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—kidney cancer	0.000593	0.0122	CbGpPWpGaD
Terlipressin—Headache—Paclitaxel—kidney cancer	0.000584	0.00119	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—OR4C13—kidney cancer	0.00058	0.012	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—OR4C13—kidney cancer	0.000576	0.0119	CbGpPWpGaD
Terlipressin—Nausea—Paclitaxel—kidney cancer	0.000554	0.00113	CcSEcCtD
Terlipressin—Diarrhoea—Capecitabine—kidney cancer	0.000524	0.00107	CcSEcCtD
Terlipressin—Hypertension—Doxorubicin—kidney cancer	0.000522	0.00106	CcSEcCtD
Terlipressin—Chest pain—Doxorubicin—kidney cancer	0.000515	0.00105	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000511	0.00104	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—OR4C13—kidney cancer	0.000494	0.0102	CbGpPWpGaD
Terlipressin—Vomiting—Capecitabine—kidney cancer	0.000487	0.000991	CcSEcCtD
Terlipressin—Nervous system disorder—Doxorubicin—kidney cancer	0.000484	0.000985	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—ANXA1—kidney cancer	0.000482	0.00995	CbGpPWpGaD
Terlipressin—Tachycardia—Doxorubicin—kidney cancer	0.000482	0.000981	CcSEcCtD
Terlipressin—Headache—Capecitabine—kidney cancer	0.00048	0.000976	CcSEcCtD
Terlipressin—Skin disorder—Doxorubicin—kidney cancer	0.000479	0.000976	CcSEcCtD
Terlipressin—AVPR1B—Peptide ligand-binding receptors—POMC—kidney cancer	0.000463	0.00954	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000456	0.00941	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000456	0.00941	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000456	0.00941	CbGpPWpGaD
Terlipressin—Nausea—Capecitabine—kidney cancer	0.000455	0.000926	CcSEcCtD
Terlipressin—AVPR2—G alpha (s) signalling events—POMC—kidney cancer	0.000448	0.00924	CbGpPWpGaD
Terlipressin—Dyspnoea—Doxorubicin—kidney cancer	0.00044	0.000896	CcSEcCtD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—ANXA1—kidney cancer	0.000439	0.00905	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—ANXA1—kidney cancer	0.000436	0.00899	CbGpPWpGaD
Terlipressin—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000426	0.000867	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—LATS1—kidney cancer	0.00042	0.00867	CbGpPWpGaD
Terlipressin—Abdominal pain—Doxorubicin—kidney cancer	0.00039	0.000794	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—AKAP13—kidney cancer	0.000382	0.00789	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—AMER1—kidney cancer	0.000357	0.00737	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—AKAP13—kidney cancer	0.000347	0.00716	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—kidney cancer	0.000345	0.00713	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—OR4C13—kidney cancer	0.000342	0.00706	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—OR4C13—kidney cancer	0.00034	0.00701	CbGpPWpGaD
Terlipressin—Diarrhoea—Doxorubicin—kidney cancer	0.000338	0.000687	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—ANXA1—kidney cancer	0.000334	0.0069	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—ANXA1—kidney cancer	0.000332	0.00685	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—ITPR2—kidney cancer	0.000325	0.00671	CbGpPWpGaD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—POMC—kidney cancer	0.000321	0.00661	CbGpPWpGaD
Terlipressin—AVPR2—Peptide ligand-binding receptors—POMC—kidney cancer	0.000318	0.00657	CbGpPWpGaD
Terlipressin—Vomiting—Doxorubicin—kidney cancer	0.000314	0.000639	CcSEcCtD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	0.00031	0.0064	CbGpPWpGaD
Terlipressin—Headache—Doxorubicin—kidney cancer	0.000309	0.000629	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—CER1—kidney cancer	0.000299	0.00618	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—GPC3—kidney cancer	0.000299	0.00618	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—ITPR2—kidney cancer	0.000295	0.00609	CbGpPWpGaD
Terlipressin—Nausea—Doxorubicin—kidney cancer	0.000293	0.000597	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—LATS1—kidney cancer	0.000291	0.00601	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—LATS1—kidney cancer	0.000289	0.00596	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—ANXA1—kidney cancer	0.000273	0.00562	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—AKAP13—kidney cancer	0.000265	0.00547	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—AKAP13—kidney cancer	0.000263	0.00543	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—SFRP2—kidney cancer	0.000255	0.00525	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	0.000249	0.00514	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—AMER1—kidney cancer	0.000248	0.00511	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—ANXA1—kidney cancer	0.000247	0.0051	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—AMER1—kidney cancer	0.000246	0.00507	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—AKAP13—kidney cancer	0.000241	0.00497	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000241	0.00496	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—kidney cancer	0.000239	0.00494	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—AKAP13—kidney cancer	0.000239	0.00493	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	0.000237	0.00489	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR ligand binding—POMC—kidney cancer	0.000236	0.00487	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000232	0.00479	CbGpPWpGaD
Terlipressin—AVPR1B—G alpha (q) signalling events—PIK3CA—kidney cancer	0.00023	0.00474	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—ITPR2—kidney cancer	0.000225	0.00465	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—ITPR2—kidney cancer	0.000224	0.00462	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	0.000224	0.00462	CbGpPWpGaD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	0.000215	0.00444	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	0.000213	0.0044	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CER1—kidney cancer	0.000207	0.00428	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—GPC3—kidney cancer	0.000207	0.00428	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CER1—kidney cancer	0.000206	0.00425	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—GPC3—kidney cancer	0.000206	0.00425	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	0.000206	0.00424	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—AKAP13—kidney cancer	0.000205	0.00423	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CASP2—kidney cancer	0.000205	0.00423	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—ITPR2—kidney cancer	0.000205	0.00422	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—ITPR2—kidney cancer	0.000203	0.00419	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—ANXA1—kidney cancer	0.000189	0.0039	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—GRB7—kidney cancer	0.000188	0.00387	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—ANXA1—kidney cancer	0.000188	0.00387	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000183	0.00378	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SFRP2—kidney cancer	0.000176	0.00364	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SFRP2—kidney cancer	0.000175	0.00361	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—ITPR2—kidney cancer	0.000174	0.0036	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	0.000173	0.00356	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—ANXA1—kidney cancer	0.000172	0.00354	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—ANXA1—kidney cancer	0.00017	0.00351	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	0.000164	0.00339	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—POMC—kidney cancer	0.000164	0.00338	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—POMC—kidney cancer	0.000163	0.00335	CbGpPWpGaD
Terlipressin—AVPR1A—G alpha (q) signalling events—PIK3CA—kidney cancer	0.000159	0.00329	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CTNNA1—kidney cancer	0.000158	0.00326	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—HSPB1—kidney cancer	0.000157	0.00324	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—EIF4EBP1—kidney cancer	0.000157	0.00324	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	0.000155	0.0032	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PSMD7—kidney cancer	0.000146	0.00302	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TSC1—kidney cancer	0.000146	0.00302	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—ANXA1—kidney cancer	0.000146	0.00302	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	0.000143	0.00294	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—AKAP13—kidney cancer	0.000142	0.00293	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CASP2—kidney cancer	0.000142	0.00293	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—FLT1—kidney cancer	0.000142	0.00292	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CASP2—kidney cancer	0.000141	0.00291	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—AKAP13—kidney cancer	0.000141	0.00291	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—POMC—kidney cancer	0.000134	0.00275	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PAK1—kidney cancer	0.000131	0.00271	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—JUNB—kidney cancer	0.000131	0.00271	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—GRB7—kidney cancer	0.00013	0.00268	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—GRB7—kidney cancer	0.000129	0.00266	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—POMC—kidney cancer	0.000121	0.0025	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ITPR2—kidney cancer	0.000121	0.00249	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ITPR2—kidney cancer	0.00012	0.00248	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CTNNA1—kidney cancer	0.00011	0.00226	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—EIF4EBP1—kidney cancer	0.000109	0.00225	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HSPB1—kidney cancer	0.000109	0.00225	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CTNNA1—kidney cancer	0.000109	0.00225	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—EIF4EBP1—kidney cancer	0.000108	0.00223	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HSPB1—kidney cancer	0.000108	0.00223	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IGF2—kidney cancer	0.000107	0.00221	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CDKN2B—kidney cancer	0.000107	0.0022	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000104	0.00214	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IGF1R—kidney cancer	0.000104	0.00214	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PSMD7—kidney cancer	0.000101	0.00209	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ANXA1—kidney cancer	0.000101	0.00209	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TSC1—kidney cancer	0.000101	0.00209	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PSMD7—kidney cancer	0.000101	0.00208	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TSC1—kidney cancer	0.000101	0.00208	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ANXA1—kidney cancer	0.000101	0.00208	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—RAF1—kidney cancer	0.0001	0.00206	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—IL2—kidney cancer	9.87e-05	0.00204	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FLT1—kidney cancer	9.81e-05	0.00202	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FLT1—kidney cancer	9.74e-05	0.00201	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—POMC—kidney cancer	9.25e-05	0.00191	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—POMC—kidney cancer	9.19e-05	0.0019	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—JUNB—kidney cancer	9.1e-05	0.00188	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PAK1—kidney cancer	9.1e-05	0.00188	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—JUNB—kidney cancer	9.03e-05	0.00186	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PAK1—kidney cancer	9.03e-05	0.00186	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL2—kidney cancer	8.96e-05	0.00185	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—HIF1A—kidney cancer	8.54e-05	0.00176	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TSC2—kidney cancer	8.52e-05	0.00176	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—POMC—kidney cancer	8.4e-05	0.00173	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—POMC—kidney cancer	8.34e-05	0.00172	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—KDR—kidney cancer	8.17e-05	0.00168	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—KIT—kidney cancer	7.52e-05	0.00155	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—APC—kidney cancer	7.52e-05	0.00155	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IGF2—kidney cancer	7.44e-05	0.00153	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CDKN2B—kidney cancer	7.4e-05	0.00153	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IGF2—kidney cancer	7.38e-05	0.00152	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CDKN2B—kidney cancer	7.35e-05	0.00152	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—MAPK3—kidney cancer	7.21e-05	0.00149	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IGF1R—kidney cancer	7.19e-05	0.00148	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—POMC—kidney cancer	7.16e-05	0.00148	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IGF1R—kidney cancer	7.14e-05	0.00147	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—BRAF—kidney cancer	7.07e-05	0.00146	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—RAF1—kidney cancer	6.93e-05	0.00143	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—RAF1—kidney cancer	6.88e-05	0.00142	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—MAPK1—kidney cancer	6.86e-05	0.00141	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—IL2—kidney cancer	6.84e-05	0.00141	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—IL2—kidney cancer	6.79e-05	0.0014	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—PIK3CA—kidney cancer	6.55e-05	0.00135	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—KRAS—kidney cancer	6.48e-05	0.00134	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL2—kidney cancer	6.21e-05	0.00128	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL2—kidney cancer	6.17e-05	0.00127	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PIK3CA—kidney cancer	5.95e-05	0.00123	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HIF1A—kidney cancer	5.92e-05	0.00122	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—RAF1—kidney cancer	5.91e-05	0.00122	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TSC2—kidney cancer	5.91e-05	0.00122	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—RELA—kidney cancer	5.88e-05	0.00121	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HIF1A—kidney cancer	5.88e-05	0.00121	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TSC2—kidney cancer	5.86e-05	0.00121	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—ERBB2—kidney cancer	5.84e-05	0.00121	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MTOR—kidney cancer	5.77e-05	0.00119	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—KDR—kidney cancer	5.66e-05	0.00117	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—KDR—kidney cancer	5.62e-05	0.00116	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CDKN1B—kidney cancer	5.41e-05	0.00112	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL2—kidney cancer	5.29e-05	0.00109	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—KIT—kidney cancer	5.22e-05	0.00108	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—APC—kidney cancer	5.22e-05	0.00108	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—KIT—kidney cancer	5.18e-05	0.00107	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—APC—kidney cancer	5.18e-05	0.00107	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCND1—kidney cancer	5.16e-05	0.00106	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—JUN—kidney cancer	5.15e-05	0.00106	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CTNNB1—kidney cancer	5.11e-05	0.00105	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—MAPK3—kidney cancer	4.99e-05	0.00103	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PTEN—kidney cancer	4.98e-05	0.00103	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—POMC—kidney cancer	4.96e-05	0.00102	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—MAPK3—kidney cancer	4.96e-05	0.00102	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—POMC—kidney cancer	4.93e-05	0.00102	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—BRAF—kidney cancer	4.9e-05	0.00101	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—BRAF—kidney cancer	4.87e-05	0.001	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—MAPK1—kidney cancer	4.75e-05	0.00098	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—MAPK1—kidney cancer	4.72e-05	0.000973	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CA—kidney cancer	4.54e-05	0.000937	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CA—kidney cancer	4.51e-05	0.00093	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—VEGFA—kidney cancer	4.5e-05	0.000928	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—KRAS—kidney cancer	4.49e-05	0.000926	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—KRAS—kidney cancer	4.46e-05	0.000919	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MAPK3—kidney cancer	4.26e-05	0.000878	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MYC—kidney cancer	4.14e-05	0.000854	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CA—kidney cancer	4.12e-05	0.000851	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CA—kidney cancer	4.09e-05	0.000845	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—RAF1—kidney cancer	4.09e-05	0.000844	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—RELA—kidney cancer	4.08e-05	0.000841	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—RAF1—kidney cancer	4.06e-05	0.000838	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MAPK1—kidney cancer	4.05e-05	0.000836	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ERBB2—kidney cancer	4.05e-05	0.000835	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—RELA—kidney cancer	4.05e-05	0.000835	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ERBB2—kidney cancer	4.02e-05	0.000829	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MTOR—kidney cancer	4e-05	0.000824	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MTOR—kidney cancer	3.97e-05	0.000818	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—KRAS—kidney cancer	3.83e-05	0.000789	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CDKN1B—kidney cancer	3.75e-05	0.000774	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CDKN1B—kidney cancer	3.72e-05	0.000768	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL2—kidney cancer	3.67e-05	0.000757	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL2—kidney cancer	3.64e-05	0.000752	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCND1—kidney cancer	3.58e-05	0.000738	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—JUN—kidney cancer	3.57e-05	0.000736	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCND1—kidney cancer	3.55e-05	0.000733	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—JUN—kidney cancer	3.54e-05	0.000731	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CTNNB1—kidney cancer	3.54e-05	0.000731	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CTNNB1—kidney cancer	3.52e-05	0.000726	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CA—kidney cancer	3.51e-05	0.000725	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PTEN—kidney cancer	3.45e-05	0.000712	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PTEN—kidney cancer	3.43e-05	0.000707	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TP53—kidney cancer	3.4e-05	0.000701	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—VEGFA—kidney cancer	3.12e-05	0.000643	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—VEGFA—kidney cancer	3.1e-05	0.000639	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MAPK3—kidney cancer	2.95e-05	0.000609	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MAPK3—kidney cancer	2.93e-05	0.000604	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MYC—kidney cancer	2.87e-05	0.000592	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MYC—kidney cancer	2.85e-05	0.000588	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MAPK1—kidney cancer	2.81e-05	0.000579	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MAPK1—kidney cancer	2.79e-05	0.000575	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—KRAS—kidney cancer	2.65e-05	0.000547	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—KRAS—kidney cancer	2.63e-05	0.000543	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CA—kidney cancer	2.44e-05	0.000503	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CA—kidney cancer	2.42e-05	0.000499	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TP53—kidney cancer	2.36e-05	0.000486	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TP53—kidney cancer	2.34e-05	0.000483	CbGpPWpGaD
